anmelden
SLI
2.143,87
PKT
+4,47
PKT
+0,21
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.10.17 | UBS Neutral | Credit Suisse Group | |
| 27.10.17 | Richemont Hold | Société Générale Group S.A. (SG) | |
| 27.10.17 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 27.10.17 | UBS overweight | JP Morgan Chase & Co. | |
| 27.10.17 | ABB (Asea Brown Boveri) Hold | Société Générale Group S.A. (SG) | |
| 27.10.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 27.10.17 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 27.10.17 | Zurich Insurance buy | Citigroup Corp. | |
| 27.10.17 | Holcim Outperform | Bernstein Research | |
| 27.10.17 | Swiss Re Neutral | Credit Suisse Group | |
| 27.10.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 26.10.17 | UBS buy | UBS AG | |
| 26.10.17 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 26.10.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 26.10.17 | Swiss Re Reduce | Commerzbank AG | |
| 26.10.17 | Novartis Outperform | Bernstein Research | |
| 25.10.17 | Holcim Outperform | Bernstein Research | |
| 25.10.17 | UBS overweight | Morgan Stanley | |
| 25.10.17 | Zurich Insurance overweight | Barclays Capital | |
| 25.10.17 | Novartis Underweight | Barclays Capital | |
| 25.10.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 25.10.17 | Novartis buy | Société Générale Group S.A. (SG) | |
| 25.10.17 | Swiss Re Sector Perform | RBC Capital Markets | |
| 25.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 25.10.17 | Swiss Re overweight | Barclays Capital | |
| 25.10.17 | Swiss Re buy | Deutsche Bank AG | |
| 24.10.17 | Novartis Hold | S&P Capital IQ | |
| 24.10.17 | Novartis buy | Baader Bank | |
| 24.10.17 | UBS buy | HSBC | |
| 24.10.17 | Zurich Insurance Hold | Kepler Cheuvreux | |
| 24.10.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 24.10.17 | Nestlé Outperform | RBC Capital Markets | |
| 24.10.17 | UBS buy | Goldman Sachs Group Inc. | |
| 24.10.17 | UBS Neutral | Goldman Sachs Group Inc. | |
| 24.10.17 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.10.17 | Roche Neutral | UBS AG | |
| 23.10.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 23.10.17 | Novartis Neutral | UBS AG | |
| 23.10.17 | UBS buy | Citigroup Corp. | |
| 23.10.17 | UBS buy | Citigroup Corp. |